AI is already accelerating drug discovery and health delivery. It has great potential to accelerate research, workflow and processes, and even reengineer entire healthcare systems. But what challenges must be addressed first? Shahram Ebadollahi and Ann Aerts share the ideas they discussed at the Intelligent Health summit in Basel this week.

Novartis’ Don Ganem tapped as a scientific advisor for the Chan Zuckerberg Biohub

Great progress has been made against malaria, but signs of resistance are becoming a rising concern

Novartis team shares results of a massive oncology experiment with the world to accelerate drug discovery.

Accelerating Research to Get Answers Faster

Oncology Regulatory Affairs Leader Hannah Mosca describes her lifelong interest in science and math, and what it’s like to work at Novartis